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Purpose: This study aims to objectively characterize the effect of successful nerve sparing (NS) during radical prostatectomy 
(RP) on postoperative urinary continence (UC) using International Index of Erectile Function (IIEF)-scores and a previously 
described Expanded Prostate Cancer Index Composite (EPIC) score cutoff value (COV) for UC. Several notable studies on 
this topic present conflicting outcomes. This is largely due to a lack of clear definitions and consensus regarding preserved 
erectile function (EF) and UC.  
Methods: This study is comprised of all patients who underwent RP at the Kantonsspital Baden, Switzerland, between 2004 
and 2013. Patients completed self-assessment questionnaires for UC (EPIC) and EF (IIEF) pre- and postoperatively (3, 6, 9, 12, 
18, and 24 months; yearly thereafter). We used a previously described EPIC subscore COV, with “satisfactory continence” sig-
nified by a score >85. Statistical analysis was performed using Kaplan-Meier and Cox regression analyses for “surgeon-” and 
“IIEF-defined” NS definitions. 
Results: Of 236 men with a median age of 63 years (interquartile range [IQR], 59–66 years) and median follow-up time of 48 
months (IQR, 30–78 months), 176 underwent unilateral (n=33) or bilateral (n=143) NS RP. Fifty-four underwent non-NS 
(NNS) RP. Kaplan-Meier analyses identified the following risk factors for UC: age, prostate volume, cancer risk group, and NS 
status. In surgeon-defined NS RP cases, multivariate analysis for regaining continence demonstrated no significant difference 
(hazard ratio [HR], 0.78; 95% confidence interval [CI], 0.48–1.25; P=0.3). With successful IIEF-defined NS RPs, regression 
analysis demonstrated no significant difference (HR, 0.89; 95% CI, 0.59–1.35; P=0.58).
Conclusions: In our population, analysis and comparison of surgeon- and IIEF-defined NS and NNS cohorts revealed that 
NS RP did not improve postoperative UC. The conservation of UC alone should not motivate surgeons or patients to pursue 
NS RP.
Keywords: Prostate; Prostatectomy; Urinary incontinence; Self-assessment
•  Research Ethics: This study was approved by the Research Ethics Committee of Ethikkommission Nordwest- und Zentralschweiz (EKNZ) 
(BASEC 2016-00323). Written informed consent was obtained from all subjects. 
•  Conflict of Interest: No potential conflict of interest relevant to this article was reported.
A Prospective Analysis of the Effects of Nerve-Sparing Radical 
Prostatectomy on Urinary Continence Based on Expanded 
Prostate Cancer Index Composite and International Index of 
Erectile Function Scoring Systems
Lukas Hefermehl1,*, Karolin Bossert1,*, Venkat M. Ramakrishnan1, Burkhardt Seifert2, Kurt Lehmann1 
1Division of Urology, Department of Surgery, Kantonsspital Baden, Baden, Switzerland
2Department of Biostatistics, University of Zürich, The Epidemiology, Biostatistics and Prevention Institute, Zürich, Switzerland
Int Neurourol J 2018;22:123-132
1 / 1CROSSMARK_logo_3_Test
2017-03-16https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg
124    www.einj.org
Hefermehl, et al.  •  A Prospective Analysis Based on EPIC and IIEF Scoring SystemsINJ
Int Neurourol J 2018;22:123-132
INTRODUCTION
While achieving the “trifecta”—being cancer-free, continent 
and potent—is the commonly anticipated goal of many radical 
prostatectomy (RP) patients, issues such as urinary inconti-
nence (UI) and erectile dysfunction (ED) are often realities that 
considerably impact their quality of life (QoL) [1]. The nerve-
sparing (NS) RP, pioneered by Walsh et al. [1] in the 1980s, 
sought to reduce rates of UI and ED through careful dissection 
of the neurovascular bundles away from the prostate during 
prostatectomy. Initial reports comparing Walsh’s approach to its 
predecessor were promising and demonstrated improved uri-
nary continence (UC). However, subsequent papers have paint-
ed a mosaic of results with variable rates of continence dictated 
by numerous potential confounders [2-9]. Such observations 
led us to question if NS RP was a clinically significant approach 
in our own patient population. With the exception of perineu-
ral invasion due to significant tumor burden, aggression, or ex-
tension, the NS RP is typically championed by urologic sur-
geons and educated patients [10].
 Even if it is successfully performed, the positive effect of NS 
on postoperative UC is controversial. Some studies from the 
past decade have emphasized that NS approaches (1) should be 
performed whenever possible and within clinical reason [8], (2) 
reduce the time to regained continence [4], and (3) do not ad-
versely affect pathologic outcomes [6]. To contrast, we and oth-
ers have suggested that there is no significant difference be-
tween NS and non-NS procedures regarding long-term conti-
nence [5,7,11]. Tzou et al. [5] indicated that the similar out-
comes of NNS and NS procedures might be attributable to large 
differences in data acquisition. Moreover, the heterogeneity of 
the definitions for continence, and especially for successful NS, 
further complicates this issue [12]. 
 There is a discrepancy between the “intention to perform” 
NS and NS that is both successful and effective. Thus, from this, 
there are 2 possible ways to define NS. One definition is derived 
from the surgeon’s operative note (surgeon-defined), which is a 
subjective definition that does not necessarily prove that the es-
sential nerves were successfully spared. A second definition is 
based on functional outcomes such as preservation of penile 
erections, which is only possible if the neurovascular bundles 
(NVB) were themselves preserved. This is an objective way of 
indicating a successful NS surgery [13,14]. 
 We surmised that if NS did indeed have an effect on conti-
nence, then there must be a correlation between potency and 
continence. Therefore, we hypothesized that the most compre-
hensive definition of effective NS would be seen in the postop-
erative recovery of erectile function per the patient Internation-
al Index of Erectile Function (IIEF)-scores (IIEF-defined). In 
consideration of the given endpoint of the study, we performed 
calculations for both surgeon-defined and IIEF-defined NS 
modalities. Here, we present the results of a prospective investi-
gation on a cohort of patients who underwent RP at our institu-
tion over a 9-year period.
MATERIALS AND METHODS
Patient Collective/Cohort
All patients who underwent open RP between January 2004 
and January 2013 at the Kantonsspital Baden, Switzerland, were 
enrolled in the study. During this period, all operations were 
performed in the same fashion by 5 surgeons; the same senior 
surgeon was present for all of the operations to provide consis-
tent oversight. Furthermore, the NS step was performed by the 
senior surgeon in all cases.
Data Acquisition
Functional data was prospectively acquired using self-assess-
ment questionnaires (described below). We also documented 
clinical and oncological data. Any missing data in the database 
was later obtained via the patients’ medical records. The data-
base was built using Access and Excel (Microsoft Corp., Red-
mond, WA, USA). 
Self-Assessment Questionnaires
All patients were given a self-assessment questionnaire preop-
eratively, 3, 9, 12, 18, and 24 months postoperatively, and yearly 
thereafter. The questionnaire was comprised of 3 sections: (1) 
the urinary domain of the “Expanded Prostate Cancer Index 
Composite” (EPIC; discussed below); (2) the IIEF (discussed 
below); and (3) our institutional Likert system-based question-
naire (also discussed below; used since 1999) to globally assess 
QoL (Appendix 1). 
Expanded Prostate Cancer Index Composite
The EPIC is a well-established and widely used instrument and 
is comprised of urinary, bowel, and sexual domains [15]. We 
used the EPIC urinary domain, which consists of 12 questions 
with 4 to 5 possible answers (symptoms related to obstruction, 
irritation, and incontinence etc.). Each question was scored on 
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a scale from 0 to 100. Subscores were summed and averaged to 
determine a total score for the whole assessment, with higher 
scores indicating better urinary function [15]. 
International Index of Erectile Function
The IIEF-EF domain is an abbreviated version of the IIEF-15 
that pertains specifically to erectile function as well as patient 
confidence in having and maintaining erections [16]. Specifi-
cally, the questionnaire is comprised of items 1, 2, 3, 4, 5, and 15 
and is scored out of 30 points; each question is worth 5 points. 
Scores of 1–10 indicate severe ED, 11–16 indicate moderate ED, 
17–21 indicate mild to moderate ED, 22–25 signify mild ED, 
and 26–30 represent no ED. For the purposes of this study, we 
state that scores <11 are ‘not potent’ and scores ≥11 are ‘potent’. 
Quality of Life
We asked questions concerning different aspects of QoL in the 
form of an internally developed 7-stepped Likert scale (0–6 
points), which conforms to those aspects comprising Interna-
tional Prostate Symptom Score/quality of life questionnaires 
(Appendix 1). 
Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics ver. 
23.0 (IBM Co., Armonk, NY, USA). To determine differences 
between groups for interval scaled and ordinal variables, we 
utilized the Mann-Whitney U-test. Categorical variables were 
appropriately compared using chi-square or Fisher exact tests. 
For continuous values, the means (with±standard deviation) 
or medians (with interquartile range) are given. Kaplan-Meier 
analysis for the recovery of continence within the follow-up 
time as well as multivariate Cox regression analyses for the 2 
NS definitions (surgeon-defined and IIEF-defined [IIEF-EF≥ 
11]) were used. Hazard ratios were presented with 95% confi-
dence intervals.
Urinary Continence
A subgroup of the EPIC score, termed the “EPIC urinary incon-
tinence” (EPIC-UI), is thought to be the most precise means of 
describing UI [17]. In an earlier publication, we determined that 
the optimal COV for “satisfactory continence” was>85 [12].
IIEF-Defined NS
We divided our analysis of IIEF-defined NS outcomes into 2 
subgroups: (1) successful NS (henceforth: “NS [EF]”) are all pa-
tients who attained an IIEF-EF score of at least 11 during their 
follow-up, and (2) a group of patients who postoperatively nev-
er reached an IIEF of 11 (NNS [EF]). Men with preoperative 
erectile dysfunction (IIEF-EF<11) were excluded from further 
analysis.
RESULTS
Between January 2004 and October 2013, 253 men underwent 
RP at our institution. Seventeen men did not complete preoper-
ative questionnaires and were consequently excluded from the 
study. All clinical data from the remaining 236 patients were 
collected and compared. Applying our previously described 
quantifiable definition of continence (EPIC-UI>85), a Kaplan-
Meier analysis demonstrated a cumulative continence rate of 
76% for the entire cohort. At 1 year postoperatively, 53% recov-
ered satisfactory continence; at 2 years, 61%; and at 3 years, 65%.
Qualitative (Surgeon-Defined) vs. Quantitative 
(Postoperative IIEF-Defined) Definitions of NS
Surgeon-defined NS RP
Supplementary Tables 1–3 demonstrate an overview of the pa-
tient data concerning oncologic and functional data regarding 
surgeon-defined NS. Six patients were excluded from the analy-
sis due to a lack of documentation regarding their NS status. 
Compared to those who underwent NS RP, patients who un-
derwent NNS RP were significantly older (median age: 65 years 
[62–69 years] vs. 63 years [58–66 years], P=0.0015) and typi-
cally had prostate disease of higher stage (proportion of pT3 tu-
mors: 44% [24 of 54] vs. 20% [34 of 174], P<0.0001) and grade 
(proportion of Gleason scores>7: 46% [25 of 54] vs. 3% [5 of 
175], P<0.0001). These patients also expressed a higher median 
prostate-specific antigen (PSA) at baseline (6.85 ng/mL [5.5–
10.22 ng/mL] vs. 5.44 ng/mL [4.21–7 ng/mL], P=0.0003) as 
well as increased median PSA density (0.19 [0.14–0.32] vs. 0.17 
[0.12–0.24], P=0.023). Macroscopic positive margins as well as 
positive lymph nodes were also more likely to occur in NNS RP 
patients versus those who underwent NS RP (R2: 15% [8 of 54] 
vs. 3% [6 of 176], P =0.005; pN1: 15% [8 of 54] vs. 3% [5 of 
176], P=0.002).
 Assessment of the surgeon-defined NS status on erectile 
function revealed a significant difference in the mean IIEF-EF 
scores between the surgeon-defined-NS and -NNS groups at 1 
year postoperatively (10±8.6 vs. 4.5±6.8, P<0.0001) (Fig. 1) as 
well as in the Kaplan-Meier estimates for the recovery of poten-
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cy (defined as an IIEF-EF>10; 60% vs. 16%, P<0.0001) (Fig. 2). 
 Preoperative erectile function appeared to be an important 
parameter for further analysis. One hundred seventeen patients 
out of those who underwent surgeon-defined NS RP demon-
strated preoperative IIEF-EF scores>10. Kaplan-Meier analysis 
revealed that 27% of these patients ultimately did not reach 
IIEF-EF scores>10 postoperatively (Fig. 3). Of those who un-
derwent surgeon-defined NNS RP without preoperative ED 
(i.e., they were considered potent, with IIEF-EF scores >10), 
20% (11 of 55) achieved postoperative IIEF-EF scores>10. 
 Collectively, these findings demonstrate a generalized failure 
rate in the surgeon’s declaration of NS status, giving sufficient 
reason to attempt a second approach to define NS status utiliz-
ing postoperative IIEF scores.
Fig. 2. Erectile function recovery (surgeon-defined NS). Kaplan-
Meier curve outlining the recovery of erectile function (IIEF-EF 
score>10) with respect to surgeon-defined NS. +/+ indicates 
censure. NS, nerve-sparing; NNS, non-NS; RP, radical prostatec-
tomy; IIEF-EF, International Index of Erectile Function (erectile 
function domain).
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Fig. 3. Erectile function in patients without pre-existing erectile 
dysfunction (ED). Kaplan-Meier curve outlining the recovery 
of erectile function (International Index of Erectile Function 
[erectile function domain] score [IIEF-EF] >10) in patients 
without preoperative total ED (IIEF-EF score≤10). NS, nerve-
sparing; RP, radical prostatectomy. + indicates censure.
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Fig. 1. Mean IIEF-EF scores over time with surgeon-defined 
nerve-sparing (NS) status. Graphical (A) and table (B) overview 
of mean IIEF-EF scores and 95% confidence intervals with re-
spect to surgeon-defined NS. IIEF-EF, International Index of 
Erectile Function (erectile function domain); RP, radical prosta-
tectomy; NNS, non-NS. P-values were measured using the 
Mann-Whitney U-test. Values are presented as mean±standard 
deviation.
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Time after RP (yr)
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A
Time NS NNS P-value
Preoperative 19±10.5 15±11.6 0.053
1.5 Months 3±3.2 4±7.2 0.079
3 Months 5±6.1 3±4.6 <0.0001
6 Months 8±7 4±5 <0.0001
9 Months 9±8.4 5±7.1 0.01
1 Year 10±8.6 4±6.8 <0.0001
1.5 Years 12±9.7 6±8.2 <0.0001
2 Years 13±9.7 6±7.2 <0.0001
3 Years 12±9.8 4±5.4 <0.0001
4.5 Years 13±9.9 2±1.6 <0.0001
6.5 Years 9±9.1 2±1.9 0.01
10 Years 9±9 3±1.6 0.22 B
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Postoperative IIEF-defined NS RP
Fifty-one men were excluded from our analyses due to preop-
erative ED (characterized by IIEF-EF scores <11). Still, we 
wished to determine if these exclusions would have yielded any 
significant findings; no significant differences in the EPIC-UI 
scores were observed at any time point between the excluded 
and remaining populations (Mann-Whitney U-test, P>0.05). 
As expected, the mean IIEF-EF scores in the excluded group 
were significantly lower preoperatively as well as during post-
operative follow-up (Mann-Whitney U-test, P<0.05).
 Supplementary Tables 4–6 depict the data at baseline as well 
as oncologic and functional data during follow-up for postop-
erative IIEF-defined NS. Patients with NNS (EF) were older (65 
years [61–67 years] vs. 62 years [56–65 years], P=0.0007), had 
a greater tumor stage (pT3: 34% [26 of 77] vs. 19% [22 of 115], 
P=0.022) and had a higher grade (Gleason score>7: 31% [24 
of 78] vs. 3% (4 of 115], P<0.0001) as well as higher PSA (6.7 
ng/mL [5.43–9.63 ng/mL] vs. 5.4 ng/mL [4.27–6.73 ng/mL], 
P<0.0001) at baseline than patients who underwent successful 
IIEF-defined NS. NNS patients also exhibited a higher rate of 
macroscopic positive margins (pR2: 10% [8 of 78] vs. 3% [3 of 
116], P=0.024) and positive lymph nodes (pN1: 13% [10 of 78] 
vs. 2% [2 of 116], P=0.002) than those who underwent suc-
cessful IIEF-defined NS.
 
Influential Factors
Through Kaplan-Meyer analyses, the following factors were 
found to negatively influence UC recovery and the postopera-
tive timepoint at which UC was achieved: higher age ( ≥63 
years, which is the median value of the respective Kaplan-Mey-
er curve), positive lymph nodes, higher prostate volume (≥33 g, 
which is also the median value of the respective Kaplan-Meyer 
curve), clinical high-risk group (RG3 as defined by D’Amico/ 
European Association of Urology & American Urological As-
sociation guidelines), and NNS (surgeon) and NNS (EF) sta-
tuses (Supplementary Fig. 1) [18]. 
 The following factors were not found to significantly influ-
ence the postoperative continence: senior surgeon performing 
the entire RP, uni- vs. bilateral NS, bilateral NS vs. unilateral 
NNS, preoperative IIEF-EF scores (>10, >18, and >21), pre-
operative continence (EPIC-UI>85), preoperative PSA values 
(<4, ≥4, <10, and ≥10), prior history of TURP or active sur-
Fig. 4. Plots of urinary continence recovery. Hazard ratio (HR) plot of Cox regressions for the recovery of urinary continence (UI-85) 
as a function of surgeon-defined nerve-sparing (NS) status (A), and IIEF-defined NS status (B), with age (years), prostate volume 
(mL), European Association of Urology risk groups (RGs) 1 & 2, and a table overview of the results shown for each of the graphs. CI, 
confidence interval; IIEF, International Index of Erectile Function.
A
HR 95% CI P-value 
0.78 0.48–1.25 0.30
0.99 0.98–1.00 0.14
0.77 0.46–1.30 0.33
0.96 0.93–0.99 0.017
NS (surgeon)
Prostate
RG
Age
Cox regression for recovery of continence
 0.4 0.6 0.8 1.0 1.2
B
HR 95% CI P-value 
0.89 0.59–1.35 0.60
0.99 0.98–1.00 0.19
0.68 0.39–1.17 0.17
0.97 0.94–1.00 0.047
NS (EF)
Prostate
RG
Age
Cox regression for recovery of continence
 0.2 0.4 0.6 0.8 1.0 1.2 1.4
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veillance, biochemical recurrence, recurrence-free survival (2 
or 5 years), use of androgen deprivation therapy, use of adju-
vant radiotherapy, Gleason score (6, 7, and ≥8), tumor stage 
(pathological or clinical), positive margins, and metastasis.
Multivariate Regression Analyses
To test the prognosis regarding “recovery of continence” for the 
complete timeframe,  parameters such as NS status, age, pros-
tate volume, and cancer risk group were assessed using the Cox 
regression in a consolidated model [18]. Lymph node status 
was excluded due to a congruent representation with the risk 
group parameter as well as the low number of men with posi-
tive status (n=13). Cox regression analyses with surgeon-de-
fined NS (Fig. 4A) as well as IIEF-defined NS (Fig. 4B) revealed 
a significant negative influence on postoperative UC for higher 
age (≥63 years) only, but not for NS status.
 To achieve maximum comparability, a Cox regression was 
performed for the binary “no pad” definition of UC as well, 
with an emphasis on the following factors: age, prostate volume, 
risk group, and NS (surgeon- and IIEF-defined) status. Neither 
surgeon- nor IIEF-defined NS statuses demonstrated signifi-
cant influences on the recurrence of postoperative UC defined 
by a lack of pad usage (Appendix 2).
DISCUSSION
Though the pathogenesis of UI after RP for most patients is 
based on the presumed intraoperative destruction of the NVB 
as well as the innervated accompanying muscle tissue, the influ-
ence of NS RP on UC preservation remains controversial 
[3,9,19,20]. Initial reports comparing Walsh’s approach to its 
predecessor were promising, respectively demonstrating rates of 
continence as high as 85% versus 16% [21]. Yet, the analysis of 
over 3 decades’ worth of international NS prostatectomies has 
yielded a notable mix of results. Flynn and Webster [22] report-
ed a high heterogeneity of outcomes, with post-RP UI spanning 
the low single-digits up to 74%. To that end, Sanda et al. [2] 
pointed to age, high PSA scores, and race as factors that affected 
post-RP UI rates. Reeves and colleagues suggested that NS RP 
ultimately resulted in earlier recovery of UC but at the 1- and 
2-year follow-ups, there was no difference in the rates of conti-
nence between those who underwent NS RP versus those who 
underwent NNS RP [7]. In totality, such studies are highly vari-
able with respect to their data analysis and interpretation [9].
 Oftentimes, the available data assessing UI or NS are ac-
quired in different descriptive manners and, at the same time, UI 
and NS often lack consistent definitions. UI for example, is often 
defined as being reliant on one or no pads, while NS is usually 
defined by the surgeon or pathology reports [3-9,12]. However, 
our study is based on self-reporting questionnaires; here, suc-
cessful NS is defined by a satisfactory functional outcome re-
garding erectile function, which proves that the cavernous nerves 
were maintained and are functional. In another regard, strongly 
influencing variables such as age have not been recognized in 
many studies [23]. Lastly, the impact of modern surgical advanc-
es (such as laparoscopic- and robotic-assisted techniques) lack 
widespread systematic assessment with respect to UI. To this 
end, a recent publication demonstrated similar functional out-
comes between open and robotic-assisted RPs [24].
 Kundu et al. [20] assessed the impacts of NS and demon-
strated similar results to ours. A positive association was seen 
between young age and preservation of continence, but none 
was seen between NS and the prevention of UI [20]. To con-
trast, Park et al. [6] analyzed a cohort of 360 patients, revealing 
significantly better UC rates with NS. However, they defined 
continence as requiring “no pad.” Slight differences from this 
definition, such as subjectively good continence despite the use 
of security pads during physical activity, were otherwise classi-
fied as “incontinent.” Furthermore, the study utilized only sur-
geon-defined NS statuses; histologic assessment of functional 
nerve preservation was not performed, and postoperative po-
tency outcome was not reported. This methodology is congru-
ent to several other studies but not all [3,8,25]. Other studies 
have defined NS in more unique ways. For example, in addition 
to using surgeon-defined NS statuses, Tzou et al. [5] performed 
a subgroup analysis with “successful NS” defined as one that ul-
timately yielded an erection “firm enough for intercourse.” Of 
note, this study did not demonstrate any influence of NS on UI. 
Taking all of this into account, we believe that the controversy 
surrounding the efficacy of NS RP on UC essentially lies with 
the definition of continence and the definition of NS. In an at-
tempt to address this, we were the first to use the EPIC scoring 
system to quantitatively define continence [12]. EPIC allowed 
us to describe continence in a more nuanced fashion, versus 
simply relying on the binary definition of “pad” vs. “no pad.” In 
this study, we expanded upon our quantitative definition of UI 
by also quantifying the functional outcomes of NS RP using the 
IIEF scoring system.  
 A point of distinction between the NNS and NS cohorts is 
that the NNS group was significantly older and their tumor 
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burden significantly larger (Supplementary Tables 2, 5). Tradi-
tional wisdom might indicate that an older group with higher tu-
mor burden (receiving NNS surgery) would have impaired conti-
nence compared to a younger group with less tumor burden (re-
ceiving NS surgery). However, we found no such differences. 
 To establish a degree of homology with prior work, we also 
performed a subanalysis using surgeon-defined NS. Here, too, 
we found no difference in UI rates between either definition of 
NS and NNS surgery. We also performed a subanalysis using 
the term “successful NS,” but strayed away from defining suc-
cess based on penile tumescence for intercourse [5]. Instead, we 
relied upon another clear, widely accepted scoring system—
IIEF—to assess potency. In all of these subanalyses, NS did not 
influence the return or preservation of UC. 
 Such results are surprising because there is a preponderance 
of data supporting the NS approach. However, our study dem-
onstrates a different approach to defining “NS,” which ultimate-
ly impacted how we assessed postoperative outcomes. Addi-
tionally, there is a growing body of work that questions the role 
of the NVB in explicitly innervating the urinary sphincters ver-
sus its more clear-cut role in innervating the penis and contrib-
uting to potency [26-29]. This is still an area of debate, as a re-
cent publication suggested that the NS technique (and not NVB 
preservation) was paramount to UC preservation [30].
 Strengths of this study include: long follow-up (up to 9 years), 
largely unchanged, single institution, and single senior surgeon.
 On the other hand a corresponding criticism to our single-
center status and geographic location would undoubtedly be hav-
ing a small cohort size. However, the number of patients in our 
study is comparable in size to several studies [7]. Furthermore, 
even if significant differences in the postoperative UC of NS and 
NNS surgeries were seen with higher patient volumes, the clinical 
relevance of NS surgery would still be called into question. 
  In conclusion, in this study, we used the IIEF-EF scoring 
system to objectively measure the postoperative success of NS 
RP and found that NS RP did not improve postoperative UC. 
NS surgery conducted with the intent of improving postopera-
tive UC is not necessarily evidence-based. Conservation of UC 
should not be the primary motivating factor in whether or not 
a patient and surgeon decide to pursue NS RP and should be 
highly questioned in the presence of preoperative ED.
SUPPLEMENTARY MATERIALS
Supplementary Tables and Figure can be found via https://doi.
org/10.5213/inj.1836052.026. 
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Appendix 1. Quality of life questionnaire      
1. How would you describe your overall quality of life?
Satisfied Happy Mostly happy Indifferent Mostly unhappy Unhappy Dissatisfied
0 1 2 3 4 5 6
2. How would you describe your quality of life regarding the changes due to your disease?
Satisfied Happy Mostly happy Indifferent Mostly unhappy Unhappy Dissatisfied
0 1 2 3 4 5 6
3. How content are you with your urinary continence?
Satisfied Happy Mostly happy Indifferent Mostly unhappy Unhappy Dissatisfied
0 1 2 3 4 5 6
4. How would you describe the quality of your sexuality?
Satisfied Happy Mostly happy Indifferent Mostly unhappy Unhappy Dissatisfied
0 1 2 3 4 5 6
5. How would you describe the quality of your partnership?
Satisfied Happy Mostly happy Indifferent Mostly unhappy Unhappy Dissatisfied
0 1 2 3 4 5 6
6. How satisfied are you with your social life (for e.g., going out, friends, hobbies)?
Satisfied Happy Mostly happy Indifferent Mostly unhappy Unhappy Dissatisfied
0 1 2 3 4 5 6
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Appendix 2. Hazard ratio (HR) plots of the Cox regressions for the recovery of continence (no pad)   
Hazard ratio (HR) plots of the Cox regressions for the recovery of continence (no pad) as a function of the following factors: (A) Sur-
geon- and (B) IIEF-defined nerve-sparing (NS), with both plots also showing age (years), prostate volume (mL), European Associa-
tion of Urology risk groups (RGs) 1 & 2, and table overviews of the results. CI, confidence interval; IIEF, International Index of Erec-
tile Function.
A
HR 95% CI P-value 
0.80 0.51–1.25 0.33
0.99 0.98–1.00 0.17
0.70 0.42–1.18 0.18
0.97 0.94–1.00 0.06
NS (surgeon)
Prostate
RG
Age
Cox regression for recovery of continence
 0.4 0.6 0.8 1.0 1.2
B
HR 95% CI P-value 
0.83 0.55–1.24 0.35
0.99 0.98–1.00 0.32
0.65 0.38–1.12 0.13
0.97 0.94–1.00 0.08
Cox regression for recovery of continence
 0.2 0.4 0.6 0.8 1.0 1.2 1.4
NS (EF)
Prostate
RG
Age
